Adiponectin in childhood

References

• Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1)79–83
   PubMed Web of Science ®Google Scholar
• Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001; 50(9)2094–9
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003; 423(6941)762–9
   PubMed Web of Science ®Google Scholar
• Araki S, Dobashi K, Kubo K, Asayama K, Shirahata A. High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J Clin Endocrinol Metab. 2006; 91(12)5113–6
   Google Scholar
• Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006; 29(6)1357–62
   PubMed Web of Science ®Google Scholar
• Nishimura R, Morimoto A, Matsudaira T, Miyashita Y, Sano H, Shirasawa T, et al. Ratio of high-, medium-, and low-molecular weight serum adiponectin to the total adiponectin value in children. J Pediatr. 2007; 151(5)545–7
   Google Scholar
• Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004; 279(13)12152–62
   PubMed Web of Science ®Google Scholar
• Trujillo ME, Scherer PE. Adiponectin–journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005; 257(2)167–75
   PubMed Web of Science ®Google Scholar
• Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes. 2003; 52(7)1779–85
   PubMed Web of Science ®Google Scholar
• Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86(5)1930–5
   PubMed Web of Science ®Google Scholar
• Delporte ML, Brichard SM, Hermans MP, Beguin C, Lambert M. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) 2003; 58(1)22–9
   Google Scholar
• Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003; 285(3)E527–33
   PubMed Web of Science ®Google Scholar
• Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003; 88(4)1594–602
   PubMed Web of Science ®Google Scholar
• Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab. 2003; 88(10)4823–31
   PubMed Web of Science ®Google Scholar
• Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003; 46(4)459–69
   PubMed Web of Science ®Google Scholar
• Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab. 2002; 87(12)5662–7
   PubMed Web of Science ®Google Scholar
• Degawa-Yamauchi M, Moss KA, Bovenkerk JE, Shankar SS, Morrison CL, Lelliott CJ, et al. Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res. 2005; 13(4)662–9
   PubMedGoogle Scholar
• Fisher FM, McTernan PG, Valsamakis G, Chetty R, Harte AL, Anwar AJ, et al. Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. Horm Metab Res. 2002; 34(11–12)650–4
   Google Scholar
• Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol. 2004; 219(1–2)9–15
   Google Scholar
• Sabin MA, Holly JM, Shield JP, Turner SJ, Grohmann MJ, Stewart CE, et al. Mature subcutaneous and visceral adipocyte concentrations of adiponectin are highly correlated in prepubertal children and inversely related to body mass index standard deviation score. J Clin Endocrinol Metab. 2006; 91(1)332–5
   Google Scholar
• Rothenbacher D, Brenner H, Marz W, Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J. 2005; 26(16)1640–6
   Google Scholar
• Vasseur F, Lepretre F, Lacquemant C, Froguel P. The genetics of adiponectin. Curr Diab Rep. 2003; 3(2)151–8
   Google Scholar
• Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002; 51(10)2968–74
   PubMed Web of Science ®Google Scholar
• Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 2002; 13(1)51–9
   PubMed Web of Science ®Google Scholar
• Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest. 2001; 108(12)1875–81
   PubMed Web of Science ®Google Scholar
• Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev. 2005; 6(1)13–21
   PubMed Web of Science ®Google Scholar
• Ravussin E. Adiponectin enhances insulin action by decreasing ectopic fat deposition. Pharmacogenomics J. 2002; 2(1)4–7
   Google Scholar
• Ravussin E, Smith SR. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2002; 967: 363–78
   PubMed Web of Science ®Google Scholar
• Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001; 98(4)2005–10
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001; 7(8)941–6
   PubMed Web of Science ®Google Scholar
• Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002; 51(6)1884–8
   PubMedGoogle Scholar
• Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology. 2002; 143(3)998–1007
   PubMed Web of Science ®Google Scholar
• Semple RK, Halberg NH, Burling K, Soos MA, Schraw T, Luan J, et al. Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes. 2007; 56(6)1712–7
   Google Scholar
• Sivan E, Mazaki-Tovi S, Pariente C, Efraty Y, Schiff E, Hemi R, et al. Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocrinol Metab. 2003; 88(12)5656–60
   PubMed Web of Science ®Google Scholar
• Tsai PJ, Yu CH, Hsu SP, Lee YH, Chiou CH, Hsu YW, et al. Cord plasma concentrations of adiponectin and leptin in healthy term neonates: positive correlation with birthweight and neonatal adiposity. Clin Endocrinol (Oxf) 2004; 61(1)88–93
   PubMed Web of Science ®Google Scholar
• Lindsay RS, Walker JD, Havel PJ, Hamilton BA, Calder AA, Johnstone FD. Adiponectin is present in cord blood but is unrelated to birth weight. Diabetes Care. 2003; 26(8)2244–9
   PubMed Web of Science ®Google Scholar
• Mantzoros C, Petridou E, Alexe DM, Skalkidou A, Dessypris N, Papathoma E, et al. Serum adiponectin concentrations in relation to maternal and perinatal characteristics in newborns. Eur J Endocrinol. 2004; 151(6)741–6
   Google Scholar
• Schmelzle HR, Fusch C. Body fat in neonates and young infants: validation of skinfold thickness versus dual-energy X-ray absorptiometry. Am J Clin Nutr. 2002; 76(5)1096–100
   PubMed Web of Science ®Google Scholar
• Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia. 2002; 45(9)1201–10
   PubMed Web of Science ®Google Scholar
• Inami I, Okada T, Fujita H, Makimoto M, Hosono S, Minato M , et al. Impact of serum adiponectin concentration on birth size and early postnatal growth. Pediatr Res. 2007;61(5 Pt 1):604–6.
   PubMed Web of Science ®Google Scholar
• Kotani Y, Yokota I, Kitamura S, Matsuda J, Naito E, Kuroda Y. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin Endocrinol (Oxf) 2004; 61(4)418–23
   PubMed Web of Science ®Google Scholar
• Pardo IM, Geloneze B, Tambascia MA, Barros-Filho AA. Hyperadiponectinemia in newborns: relationship with leptin levels and birth weight. Obes Res. 2004; 12(3)521–4
   Google Scholar
• Iniguez G, Soto N, Avila A, Salazar T, Ong K, Dunger D, et al. Adiponectin levels in the first two years of life in a prospective cohort: relations with weight gain, leptin levels and insulin sensitivity. J Clin Endocrinol Metab. 2004; 89(11)5500–3
   Google Scholar
• Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet. 1989; 2(8663)577–80
   PubMed Web of Science ®Google Scholar
• Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993; 36(1)62–7
   PubMed Web of Science ®Google Scholar
• Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991; 303(6809)1019–22
   PubMed Web of Science ®Google Scholar
• Ong KK, Petry CJ, Emmett PM, Sandhu MS, Kiess W, Hales CN, et al. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia. 2004; 47(6)1064–70
   PubMed Web of Science ®Google Scholar
• Gluckman P, Hanson M. The Fetal Matrix: Evolution, Development and Disease. Cambridge University Press, Cambridge 2005
   Google Scholar
• Cianfarani S, Martinez C, Maiorana A, Scire G, Spadoni GL, Boemi S. Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal catch-up growth. J Clin Endocrinol Metab. 2004; 89(3)1346–51
   PubMed Web of Science ®Google Scholar
• Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, et al. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab. 1997; 82(2)402–6
   Google Scholar
• Leger J, Levy-Marchal C, Bloch J, Pinet A, Chevenne D, Porquet D, et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. BMJ. 1997; 315(7104)341–7
   Google Scholar
• Kamoda T, Saitoh H, Saito M, Sugiura M, Matsui A. Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatr Res. 2004; 56(5)690–3
   PubMed Web of Science ®Google Scholar
• Kim CS, Park JS, Park J, Nam JS, Kang ES, Ahn CW, et al. Does birthweight predict adolescent adiponectin levels?. Clin Endocrinol (Oxf) 2006; 64(2)162–8
   PubMed Web of Science ®Google Scholar
• Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab. 2002; 87(10)4652–6
   PubMed Web of Science ®Google Scholar
• Asayama K, Hayashibe H, Dobashi K, Uchida N, Nakane T, Kodera K, et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res. 2003; 11(9)1072–9
   Google Scholar
• Nemet D, Wang P, Funahashi T, Matsuzawa Y, Tanaka S, Engelman L, et al. Adipocytokines, body composition, and fitness in children. Pediatr Res. 2003; 53(1)148–52
   PubMedGoogle Scholar
• Punthakee Z, Delvin EE, O'loughlin J, Paradis G, Levy E, Platt RW, et al. Adiponectin, adiposity, and insulin resistance in children and adolescents. J Clin Endocrinol Metab. 2006; 91(6)2119–25
   Google Scholar
• Valle M, Martos R, Gascon F, Canete R, Zafra MA, Morales R. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab. 2005; 31(1)55–62
   PubMed Web of Science ®Google Scholar
• Jeffery AN, Alba S, Murphy MJ, Voss LD, Metcalf BS, Hosking J, et al. Behavior of insulin resistance and its metabolic correlates in prepubertal children: a longitudinal study (EarlyBird 32). Diabetes Care. 2007; 30(11)2962–4
   Google Scholar
• Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care. 2004; 27(2)547–52
   PubMed Web of Science ®Google Scholar
• Bush NC, Darnell BE, Oster RA, Goran MI, Gower BA. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes. 2005; 54(9)2772–8
   Google Scholar
• Cruz M, Garcia-Macedo R, Garcia-Valerio Y, Gutierrez M, Medina-Navarro R, Duran G, et al. Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care. 2004; 27(6)1451–3
   Google Scholar
• Lee S, Bacha F, Gungor N, Arslanian SA. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care. 2006; 29(1)51–6
   Google Scholar
• Weiss R, Dufour S, Groszmann A, Petersen K, Dziura J, Taksali SE, et al. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab. 2003; 88(5)2014–8
   Google Scholar
• Degawa-Yamauchi M, Dilts JR, Bovenkerk JE, Saha C, Pratt JH, Considine RV. Lower serum adiponectin levels in African-American boys. Obes Res. 2003; 11(11)1384–90
   Google Scholar
• Jeffery A, Alba S, Murphy M, Voss L, Metcalf B, Hosking J, et al. The Behaviour of Insulin Resistance and its Metabolic Correlates in Prepubertal Children-A Longitudinal Study. Diabetes Care. 2007; 30(11)2962–4
   Google Scholar
• Kettaneh A, Heude B, Oppert JM, Scherer P, Meyre D, Borys JM, et al. Serum adiponectin is related to plasma high-density lipoprotein cholesterol but not to plasma insulin-concentration in healthy children: the FLVS II study. Metabolism. 2006; 55(9)1171–6
   Google Scholar
• Tsou PL, Jiang YD, Chang CC, Wei JN, Sung FC, Lin CC, et al. Sex-related differences between adiponectin and insulin resistance in schoolchildren. Diabetes Care. 2004; 27(2)308–13
   Google Scholar
• Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K. Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents. Metabolism. 2004; 53(10)1336–41
   Google Scholar
• Weiss R, Taksali SE, Dufour S, Yeckel CW, Papademetris X, Cline G, et al. The “obese insulin-sensitive” adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab. 2005; 90(6)3731–7
   Google Scholar
• Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab. 2004; 89(8)4053–61
   Google Scholar
• Ong KK, Frystyk J, Flyvbjerg A, Petry CJ, Ness A, Dunger DB. Sex-discordant associations with adiponectin levels and lipid profiles in children. Diabetes. 2006; 55(5)1337–41
   Google Scholar
• Andersen KK, Frystyk J, Wolthers OD, Heuck C, Flyvbjerg A. Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. J Clin Endocrinol Metab. 2007; 92(5)1857–62
   Google Scholar
• Martos-Moreno GA, Barrios V, Argente J. Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids. Eur J Endocrinol. 2006; 155(3)429–34
   PubMed Web of Science ®Google Scholar
• Woo JG, Dolan LM, Daniels SR, Goodman E, Martin LJ. Adolescent sex differences in adiponectin are conditional on pubertal development and adiposity. Obes Res. 2005; 13(12)2095–101
   Google Scholar
• Lanfranco F, Zitzmann M, Simoni M, Nieschlag E. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin Endocrinol (Oxf) 2004; 60(4)500–7
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci. 1999; 892: 146–54
   PubMed Web of Science ®Google Scholar
• Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000; 96(5)1723–32
   PubMed Web of Science ®Google Scholar
• Yokota T, Meka CS, Kouro T, Medina KL, Igarashi H, Takahashi M, et al. Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol. 2003; 171(10)5091–9
   Google Scholar
• Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100(25)2473–6
   PubMed Web of Science ®Google Scholar
• Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291(14)1730–7
   PubMed Web of Science ®Google Scholar
• Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation. 2006; 114(7)623–9
   PubMed Web of Science ®Google Scholar
• Laughlin GA, Barrett-Connor E, May S, Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol. 2007; 165(2)164–74
   Google Scholar
• Wannamethee SG, Whincup PH, Lennon L, Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Itern Med. 2007; 167(14)1510–7
   Google Scholar
• Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006; 17(9)2599–606
   PubMed Web of Science ®Google Scholar
• Gil-Campos M, Canete R, Gil A. Hormones regulating lipid metabolism and plasma lipids in childhood obesity. Int J Obes Relat Metab Disord 2004; 28(Suppl 3)S75–80
   Google Scholar
• Winer JC, Zern TL, Taksali SE, Dziura J, Cali AM, Wollschlager M, et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab. 2006; 91(11)4415–23
   PubMed Web of Science ®Google Scholar
• Shaibi GQ, Cruz ML, Weigensberg MJ, Toledo-Corral CM, Lane CJ, Kelly LA, et al. Adiponectin independently predicts metabolic syndrome in overweight Latino youth. J Clin Endocrinol Metab. 2007; 92(5)1809–13
   Google Scholar
• Pilz S, Horejsi R, Moller R, Almer G, Scharnagl H, Stojakovic T, et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab. 2005; 90(8)4792–6
   Google Scholar
• Litwin M, Sladowska J, Antoniewicz J, Niemirska A, Wierzbicka A, Daszkowska J, et al. Metabolic abnormalities, insulin resistance, and metabolic syndrome in children with primary hypertension. Am J Hypertens. 2007; 20(8)875–82
   Google Scholar
• Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999–2000. Circulation. 2003; 108(9)1053–8
   Google Scholar
• Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004; 350(23)2362–74
   PubMed Web of Science ®Google Scholar
• Sargin H, Sargin M, Gozu H, Orcun A, Baloglu G, Ozisik M, et al. Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients?. World J Gastroenterol. 2005; 11(37)5874–7
   Google Scholar
• Targher G, Bertolini L, Rodella S, Zoppini G, Scala L, Zenari L, et al. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 2006; 64(6)679–83
   Google Scholar
• Louthan MV, Barve S, McClain CJ, Joshi-Barve S. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J Pediatr. 2005; 147(6)835–8
   Google Scholar
• Zou CC, Liang L, Hong F, Fu JF, Zhao ZY. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr J. 2005; 52(5)519–24
   PubMed Web of Science ®Google Scholar
• Rodriguez G, Moreno LA, Sarria A, Pineda I, Fleta J, Perez-Gonzalez JM, et al. Determinants of resting energy expenditure in obese and non-obese children and adolescents. J Physiol Biochem. 2002; 58(1)9–15
   Google Scholar
• DeLany JP, Bray GA, Harsha DW, Volaufova J. Energy expenditure and substrate oxidation predict changes in body fat in children. Am J Clin Nutr. 2006; 84(4)862–70
   Google Scholar
• Goran MI, Shewchuk R, Gower BA, Nagy TR, Carpenter WH, Johnson RK. Longitudinal changes in fatness in white children: no effect of childhood energy expenditure. Am J Clin Nutr. 1998; 67(2)309–16
   Google Scholar
• Griffiths M, Payne PR, Stunkard AJ, Rivers JP, Cox M. Metabolic rate and physical development in children at risk of obesity. Lancet. 1990; 336(8707)76–8
   Google Scholar
• Grillol LP, Siqueira AF, Silva AC, Martins PA, Verreschi IT, Sawaya AL. Lower resting metabolic rate and higher velocity of weight gain in a prospective study of stunted vs nonstunted girls living in the shantytowns of Sao Paulo, Brazil. Eur J Clin Nutr. 2005; 59(7)835–42
   Google Scholar
• Johnson MS, Figueroa-Colon R, Herd SL, Fields DA, Sun M, Hunter GR, et al. Aerobic fitness, not energy expenditure, influences subsequent increase in adiposity in black and white children. Pediatrics. 2000; 106(4)E50
   PubMed Web of Science ®Google Scholar
• Stunkard AJ, Berkowitz RI, Stallings VA, Schoeller DA. Energy intake, not energy output, is a determinant of body size in infants. Am J Clin Nutr. 1999; 69(3)524–30
   Google Scholar
• Stunkard AJ, Berkowitz RI, Schoeller D, Maislin G, Stallings VA. Predictors of body size in the first 2 y of life: a high-risk study of human obesity. Int J Obes Relat Metab Disord. 2004; 28(4)503–13
   Google Scholar
• Ruige JB, Ballaux DP, Funahashi T, Mertens IL, Matsuzawa Y, Van Gaal LF. Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders. Am J Clin Nutr. 2005; 82(1)21–5
   Google Scholar
• Pannacciulli N, Bunt JC, Ortega E, Funahashi T, Salbe AD, Bogardus C, et al. Lower total fasting plasma adiponectin concentrations are associated with higher metabolic rates. J Clin Endocrinol Metab. 2006; 91(4)1600–3
   Google Scholar
• Hosking J, Metcalf BS, Jeffery AN, Gardner D, Voss LD, Wilkin TJ. Resting energy expenditure, adiponectin and changes in body composition of young children (EarlyBird 34). Int J Pediatr Obes. 2007;1–6.
   Google Scholar
• Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism. 2004; 53(1)1–3
   Google Scholar
• Bacha F, Saad R, Gungor N, Arslanian SA. Does adiponectin explain the lower insulin sensitivity and hyperinsulinemia of African-American children?. Pediatr Diabetes. 2005; 6(2)100–2
   Google Scholar
• Cianflone K, Lu H, Smith J, Yu W, Wang H. Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children. Clin Endocrinol (Oxf) 2005; 62(5)567–72
   Web of Science ®Google Scholar
• Huang KC, Lue BH, Yen RF, Shen CG, Ho SR, Tai TY, et al. Plasma adiponectin levels and metabolic factors in nondiabetic adolescents. Obes Res. 2004; 12(1)119–24
   PubMedGoogle Scholar
• Martin LJ, Woo JG, Daniels SR, Goodman E, Dolan LM. The relationships of adiponectin with insulin and lipids are strengthened with increasing adiposity. J Clin Endocrinol Metab. 2005; 90(7)4255–9
   Google Scholar